Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 205

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost

Open access
Suh, Yun‐Suhk, Lee, Joonki, Woo, Hyeongtaek, Shin, Dongwook, Kong, Seong‐Ho, Lee, Hyuk‐Joon, Shin, Aesun, Yang, Han‐Kwang · 2020 · Cancer

Abstract

Background: The purpose of this study was to evaluate the nationwide benefit and cost of the national cancer screening program (NCSP) for gastric cancer treatment. Methods: For this nationwide, population‐based study, the Korean National Health Insurance Big Data Base, which included gastric cancer–related treatment information and the costs for all patients with gastric cancer who were 40 years old or older between 2004 and 2013, was restructured. Patients with gastric cancer who participated in the NCSP at least once (the screening group) were compared with those who did not participate in the NCSP (the nonscreening group). Results: The screening group (n = 116,775) spent significantly less on medical care expenses than the nonscreening group (n = 74,927) during the 5 years since the initial treatment ( P < .0001). The screening group presented a significantly better prognosis for 5 and 9 years than the nonscreening group ( P < .0001). The screening group revealed a 41% decreased hazard ratio ( P < .0001) for death in comparison with the nonscreening group; the prognostic benefit became more obvious when treatment was started within the first 4 months after screening. The age‐standardized mortality rate ratio of the screening group versus the nonscreening group was 0.62 ( P < .0001). The NCSP for gastric cancer required an average of 22,169,769 Korean Republic won (US $20,309) for 1 life‐year saved, which was less than the average gross domestic product (GDP) per capita in Korea. Conclusions: The screening group had significantly lower medical care expenses and showed a significantly better prognosis than the nonscreening group. On the basis of the GDP per capita, the NCSP for gastric cancer was cost‐effective for treatment prognosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.32753

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 205

Metadata

Authors
Suh, Y., Lee, J., Woo, H., Shin, D., Kong, S., Lee, H., Shin, A., & Yang, H.
Venue
Cancer
Publisher
Wiley
Published
2020-02-07
Volume
126
Issue
9
Pages
1929-1939
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W3005271782
Cited by
205
References
3
FWCI
11.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost. https://app.cochat.ai/papers/10.1002/cncr.32753
The paper
Suh, Y., Lee, J., Woo, H., Shin, D., Kong, S., Lee, H., Shin, A., & Yang, H. (2020). National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost. Cancer. https://doi.org/10.1002/cncr.32753

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.